Detalles del proyecto
Description
ABSTRACT
The renin-angiotensin system plays a pivotal role in atherogenesis; however, the evolving
mechanism responsible for this pathogenic effect remains undefined. Angiotensin II (AngII)
type 1 receptor (AT1R in humans; AT1aR in mice) is the primary receptor through which
AngII, the major bioactive peptide, exerts its effects on atherosclerosis. My sponsors’ long-
term research has demonstrated that AT1aR activation contributes to atherosclerosis;
however, AT1aR in myeloid cells, endothelial cells, or smooth muscle cells, did not affect
atherosclerosis, as determined in hypercholesterolemic mice with cell-specific deletion of
AT1aR. My preliminary studies using single-cell and spatial RNA sequencing revealed that
AT1aR expression is predominantly localized to fibroblasts, abundant with decorin (DCN+)
in both human and mouse atherosclerosis. In normal aortic wall, DCN+ cells are restricted
to the adventitia; however, during atherosclerosis development and progression, DCN+
cells are present not only in the adventitia but also in the media and atherosclerotic
plaques, accompanied by increased collagen 1A1 expression and decreased actin alpha 2
expression, indicating phenotypic changes in DCN+ cells. Recently, my sponsors
developed Dcn-Cre ERT2 mice, which provided evidence that Dcn-lineage cells are
predominantly in the adventitia of normal aortas. Based on my preliminary data and the
long-standing work from my sponsors’ lab, I hypothesize that AT1aR activation drives Dcn-
lineage cell migration and proliferation, thereby promoting atherosclerosis development and
progression. Two aims are proposed to test this hypothesis. Aim 1 will use our unique Dcn-
CreERT2; mT/mG mice to track DCN-lineage cell fate and phenotypic changes in
hypercholesterolemic mice. I will also culture Dcn-lineage cells to examine their response to
oxidized LDL. Aim 2 will determine whether AT1aR in Dcn-lineage cells contributes to
atherosclerosis in hypercholesterolemic mice.
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 1/1/26 → 12/31/27 |
Financiación
- American Heart Association: 77.432,00 US$
Huella digital
Explore los temas de investigación que se abordan en este proyecto. Estas etiquetas se generan con base en las adjudicaciones/concesiones subyacentes. Juntos, forma una huella digital única.